Select Page

As we close out 2025, I want to sincerely thank our customers and partners for your trust, collaboration, and shared commitment to improving patient care.

This year marked meaningful progress for Mercury Medical, from the growing acceptance of our Flow-Safe II+ BiLevel CPAP device in acute care settings to clinicians seeing real success Flow-Safing PACU patients with obstructive sleep apnea (OSA). We also saw strong momentum behind our latest new product launches, bringing innovations like the Airtraq +Plus Video Laryngoscope System and the EpiFaith Smart Syringe to clinicians nationwide. Together, these advancements reflect our continued focus on delivering clinically differentiated solutions that help save lives.

We are proud of what we’ve accomplished together and energized by the opportunities ahead in 2026. Thank you for being part of our journey, we look forward to continuing to serve you in the year ahead.

— John Gargaro, MD

CEO, Mercury Medical